News & Updates

Over $4,000 raised at Loch Bar

Friday, October 25, 2024

On Monday, October 21, 2024, more than 200 guests gathered at Loch Bar Philadelphia in support of Philly Fights Cancer, raising $4,125 for Penn Medicine’s Abramson Cancer Center. The benefit day was an outstanding success, with patrons filling the restaurant throughout lunch, happy hour, and dinner service.

Loch Bar demonstrated its commitment to the cause by donating 25% of the day's proceeds, playing a significant role in advancing cancer research and care.

Philly Fights Cancer extends its sincere gratitude to all who attended and contributed to the success of the event. For those unable to join, we encourage you to stay informed about future opportunities to support this critical mission.

Two women posing for photo at fine dining tablescene at restaurant at night of diners enjoying their meals Glass seafood bar with lobster, oysters and other seafood on display for those enjoying dinner at a barTwo women posing together at dining tableMen at bar watching sports exterior of restaurant at night

Want to stay informed?

Sign-up for Our Newsletter
for Philly Fights Cancer News.

Sign Up

On Monday, October 21, 2024, more than 200 guests gathered at Loch Bar Philadelphia in support of Philly Fights Cancer, raising $4,125 for Penn Medicine’s Abramson Cancer Center. The benefit day was an outstanding success, with patrons filling the restaurant throughout lunch, happy hour, and dinner service.

Loch Bar demonstrated its commitment to the cause by donating 25% of the day's proceeds, playing a significant role in advancing cancer research and care.

Philly Fights Cancer extends its sincere gratitude to all who attended and contributed to the success of the event. For those unable to join, we encourage you to stay informed about future opportunities to support this critical mission.

Two women posing for photo at fine dining tablescene at restaurant at night of diners enjoying their meals Glass seafood bar with lobster, oysters and other seafood on display for those enjoying dinner at a barTwo women posing together at dining tableMen at bar watching sports exterior of restaurant at night

News & Updates

October is Breast Cancer Awareness Month

Thursday, October 10, 2024

October marks Breast Cancer Awareness Month, and Philly Fights Cancer remains committed to supporting the advancement of clinical trials and research aimed at improving cancer treatment, including breast cancer, at the Abramson Cancer Center (ACC).

 

Breast cancer is the most common cancer among women worldwide, with an estimated 1 in 8 women developing the disease in their lifetime. In the United States alone, over 280,000 new cases of invasive breast cancer are diagnosed each year. Early detection through regular screenings, such as mammograms, plays a critical role in improving outcomes, as it can identify cancer at an earlier, more treatable stage. Studies show that when breast cancer is detected early, the five-year survival rate exceeds 90%. Regular screening, coupled with advances in treatment, has contributed to a steady decline in breast cancer mortality rates, underscoring the vital importance of early detection in saving lives.

 

Abramson Cancer Center offers a comprehensive breast cancer program, encompassing screenings, specialized care, and access to cutting-edge clinical trials led by expert oncologists. Clinical trials are a cornerstone of medical innovation, providing patients with access to novel therapies that have the potential to improve outcomes while contributing to critical advancements in healthcare.

 

For more information on these essential clinical trials for breast cancer treatment, visit: https://www.pennmedicine.org/resear.../find-a-clinical-trial.

Graphic showing 1 in 8 women will be diagnosed with breast cancer in their lifetime.
1 in 8 Women will be diagnosed with breast cancer in their lifetime.

Want to stay informed?

Sign-up for Our Newsletter
for Philly Fights Cancer News.

Sign Up

October marks Breast Cancer Awareness Month, and Philly Fights Cancer remains committed to supporting the advancement of clinical trials and research aimed at improving cancer treatment, including breast cancer, at the Abramson Cancer Center (ACC).

 

Breast cancer is the most common cancer among women worldwide, with an estimated 1 in 8 women developing the disease in their lifetime. In the United States alone, over 280,000 new cases of invasive breast cancer are diagnosed each year. Early detection through regular screenings, such as mammograms, plays a critical role in improving outcomes, as it can identify cancer at an earlier, more treatable stage. Studies show that when breast cancer is detected early, the five-year survival rate exceeds 90%. Regular screening, coupled with advances in treatment, has contributed to a steady decline in breast cancer mortality rates, underscoring the vital importance of early detection in saving lives.

 

Abramson Cancer Center offers a comprehensive breast cancer program, encompassing screenings, specialized care, and access to cutting-edge clinical trials led by expert oncologists. Clinical trials are a cornerstone of medical innovation, providing patients with access to novel therapies that have the potential to improve outcomes while contributing to critical advancements in healthcare.

 

For more information on these essential clinical trials for breast cancer treatment, visit: https://www.pennmedicine.org/resear.../find-a-clinical-trial.

Graphic showing 1 in 8 women will be diagnosed with breast cancer in their lifetime.
1 in 8 Women will be diagnosed with breast cancer in their lifetime.